Gem Aromatics Ltd
Incorporated in October 1997, Gem Aromatics Limited manufactures speciality ingredients, including essential oils, aroma chemicals, and Value-Added Derivatives in India.[1]
- Market Cap ₹ 1,422 Cr.
- Current Price ₹ 272
- High / Low ₹ 350 / 262
- Stock P/E 25.0
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 22.8 %
- ROE 22.2 %
- Face Value ₹ 2.00
Pros
Cons
- Company might be capitalizing the interest cost
- Debtor days have increased from 67.7 to 101 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE IPO
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| 447 | 497 | |
| 372 | 411 | |
| Operating Profit | 76 | 86 |
| OPM % | 17% | 17% |
| 3 | 5 | |
| Interest | 6 | 7 |
| Depreciation | 6 | 7 |
| Profit before tax | 67 | 77 |
| Tax % | 26% | 26% |
| 49 | 57 | |
| EPS in Rs | 10.56 | 12.13 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 22% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Equity Capital | 9 | 9 |
| Reserves | 218 | 275 |
| 85 | 145 | |
| 19 | 18 | |
| Total Liabilities | 331 | 447 |
| 37 | 37 | |
| CWIP | 2 | 6 |
| Investments | 1 | 1 |
| 292 | 403 | |
| Total Assets | 331 | 447 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| 42 | -12 | |
| -25 | -54 | |
| -12 | 50 | |
| Net Cash Flow | 6 | -16 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 35 | 101 |
| Inventory Days | 180 | 151 |
| Days Payable | 16 | 15 |
| Cash Conversion Cycle | 199 | 236 |
| Working Capital Days | 124 | 114 |
| ROCE % | 23% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Newspaper Publication for unaudited Financial Results for quarter ended June 30, 2025.
-
Intimation Under Regulation 30(5) Of The SEBI (LODR) Regulations, 2015
12 Sep - Board authorised MD Yash Parekh and WTD/CFO Kaksha Parekh for materiality determination and disclosures (12 Sep 2025).
-
Intimation Under Regulation 8(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
12 Sep - Code for Fair Disclosure amended and adopted on September 12, 2025.
- Quarterly Financial Results As On June 30, 2025 12 Sep
-
Board Meeting Outcome for Outcome Of Board Meeting For Approval Of Quarterly Unaudited Financial Results As On June 30, 2025
12 Sep - Approved Q1 June 30, 2025 unaudited results; IPO 13,884,615 shares at ₹325 listed Aug 26, 2025.
Business Profile[1][2]
The company specializes in producing high-quality essential oils, aroma chemicals, and value-added derivatives. It has a strong foundation in mint- and clove-based products and growing capabilities in eucalyptus and phenol derivatives, it offers a portfolio of around 70 products across four categories. These ingredients find wide applications in oral care, cosmetics, nutraceuticals, pharmaceuticals, wellness and pain management, as well as personal care segments.